Health Affairs Study Deflects New Tech Cost Critics; JEC Report Forthcoming
This article was originally published in The Gray Sheet
Executive Summary
An article in the 1July/August issue of Health Affairs cites economic data from FDA Commissioner Mark McClellan to argue that thwarted access to new medical technologies among the uninsured yields $1.1 bil. in lost annual net benefits